A cut plotline from It's Always Sunny In Philadelphia and Abbott Elementary's crossover almost provided an expansion to a notable season 7 episode.

Abbott Laboratories remains a top pick in volatile markets thanks to strong fundamentals and regulatory tailwinds.

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

Today we will run through one way of estimating the intrinsic value of Abbott Laboratories (NYSE:ABT) by projecting its future cash flows and then discounting them to today's value. This will be ...

Abbott Laboratories provides exposure to multiple areas of healthcare. AbbVie offers growth, income, and an attractive valuation. I don't know if we'll be riding in personal aircraft 20 years from ...

Abbott Laboratories (NYSE:ABT) is one of the Best Dividend Stocks of 2025. In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite ...

Abbott Laboratories (NYSE: ABT) was founded in 1888. Today, it ranks among the world's most successful healthcare companies and has a market cap of $240 billion.

Comparing Abbott Laboratories's Short Interest Against Its Peers Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing.

The 2025 TIME 100 Most Influential Companies list includes over 40 companies that investors can buy stock in.

Hamdard Laboratories (Waqf) Bangladesh has taken a significant step towards modernising its reach by signing a memorandum of understanding with technology partner Bizmation and delivery partner Pathao ...

Oppenheimer found two significant catalysts for Abbott Laboratories (NYSE:ABT) that might boost the company’s performance in the second half of 2025.